These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25636036)

  • 1. A time to kill: targeting apoptosis in cancer.
    Koff JL; Ramachandiran S; Bernal-Mizrachi L
    Int J Mol Sci; 2015 Jan; 16(2):2942-55. PubMed ID: 25636036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
    Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
    Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TRAIL DISCussion: It is FADD and caspase-8!
    Peter ME
    Cell Death Differ; 2000 Sep; 7(9):759-60. PubMed ID: 11042670
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G; Schulze-Osthoff K; Jänicke RU
    Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis signaling in tumor therapy.
    Fulda S; Debatin KM
    Ann N Y Acad Sci; 2004 Dec; 1028():150-6. PubMed ID: 15650241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
    J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors.
    Schimmer AD; Thomas MP; Hurren R; Gronda M; Pellecchia M; Pond GR; Konopleva M; Gurfinkel D; Mawji IA; Brown E; Reed JC
    Cancer Res; 2006 Feb; 66(4):2367-75. PubMed ID: 16489043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL-induced apoptosis in U-1242 MG glioma cells.
    Saqr HE; Omran OM; Oblinger JL; Yates AJ
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):152-61. PubMed ID: 16462206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances for research on anti-tumor effects of TNF-related apoptosis-inducing ligand].
    Yao GH; Hou YY
    Wei Sheng Yan Jiu; 2006 Jan; 35(1):115-7. PubMed ID: 16598953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
    Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
    Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does "death receptor" signaling play a role in tumorigenesis and cancer therapy?
    Villunger A; Strasser A
    Oncol Res; 1998; 10(11-12):541-50. PubMed ID: 10367935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis signaling pathways and lymphocyte homeostasis.
    Xu G; Shi Y
    Cell Res; 2007 Sep; 17(9):759-71. PubMed ID: 17576411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
    Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
    Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Messengers of cell death: apoptotic signaling in health and disease.
    Rossi D; Gaidano G
    Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.